Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells

Stordal, B; Davey, MW; Davey, RA

Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells

Stordal, B Davey, MW Davey, RA

Permalink

Publisher:: Springer
Publication Type:: Journal Article
Citation:: Cancer Chemotherapy And Pharmacology, 2006, 58 (2), pp. 256 - 265
Issue Date:: 2006-01

Closed Access

	Filename	Description	Size
	2006003986OK.pdf		541.12 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Stordal, B	en_US
dc.contributor.author	Davey, MW	en_US
dc.contributor.author	Davey, RA	en_US
dc.date.issued	2006-01	en_US
dc.identifier.citation	Cancer Chemotherapy And Pharmacology, 2006, 58 (2), pp. 256 - 265	en_US
dc.identifier.issn	0344-5704	en_US
dc.identifier.uri	http://hdl.handle.net/10453/9477
dc.description.abstract	Cisplatin produces good responses in solid tumours including small cell lung cancer (SCLC) but this is limited by the development of resistance. Oxaliplatin is reported to show activity against some cisplatin-resistant cancers but there is little known a	en_US
dc.publisher	Springer	en_US
dc.relation.ispartof	Cancer Chemotherapy And Pharmacology	en_US
dc.relation.isbasedon	10.1007/s00280-005-0148-7	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.title	Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	58	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	closed_access
pubs.consider-herdc	false	en_US
pubs.issue	2	en_US
pubs.volume	58	en_US

Abstract:

Cisplatin produces good responses in solid tumours including small cell lung cancer (SCLC) but this is limited by the development of resistance. Oxaliplatin is reported to show activity against some cisplatin-resistant cancers but there is little known a

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/9477